Details for New Drug Application (NDA): 022288
✉ Email this page to a colleague
The generic ingredient in BEPREVE is bepotastine besilate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bepotastine besilate profile page.
Summary for 022288
Tradename: | BEPREVE |
Applicant: | Bausch And Lomb Inc |
Ingredient: | bepotastine besilate |
Patents: | 1 |
Suppliers and Packaging for NDA: 022288
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BEPREVE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 022288 | NDA | Bausch & Lomb Incorporated | 24208-629 | 24208-629-01 | 1 BOTTLE, DROPPER in 1 CARTON (24208-629-01) / 10 mL in 1 BOTTLE, DROPPER |
BEPREVE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 022288 | NDA | Bausch & Lomb Incorporated | 24208-629 | 24208-629-02 | 1 BOTTLE, DROPPER in 1 CARTON (24208-629-02) / 5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1.5% | ||||
Approval Date: | Sep 8, 2009 | TE: | AT | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 13, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 022288
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | BEPREVE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 022288-001 | Sep 8, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Bausch And Lomb Inc | BEPREVE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 022288-001 | Sep 8, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription